266 related articles for article (PubMed ID: 31429524)
1. Inflammatory markers in intrahepatic cholangiocarcinoma: Effects of advanced liver disease.
Sellers CM; Uhlig J; Ludwig JM; Stein SM; Kim HS
Cancer Med; 2019 Oct; 8(13):5916-5929. PubMed ID: 31429524
[TBL] [Abstract][Full Text] [Related]
2. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
3. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
[TBL] [Abstract][Full Text] [Related]
4. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
[TBL] [Abstract][Full Text] [Related]
5. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
6. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
[TBL] [Abstract][Full Text] [Related]
7. The systemic immune-inflammation index predicts prognosis in intrahepatic cholangiocarcinoma: an international multi-institutional analysis.
Tsilimigras DI; Moris D; Mehta R; Paredes AZ; Sahara K; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Soubrane O; Koerkamp BG; Endo I; Pawlik TM
HPB (Oxford); 2020 Dec; 22(12):1667-1674. PubMed ID: 32265108
[TBL] [Abstract][Full Text] [Related]
8. The impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma.
Buettner S; Spolverato G; Kimbrough CW; Alexandrescu S; Marques HP; Lamelas J; Aldrighetti L; Gamblin TC; Maithel SK; Pulitano C; Weiss M; Bauer TW; Shen F; Poultsides GA; Marsh JW; IJzermans JNM; Koerkamp BG; Pawlik TM
Surgery; 2018 Sep; 164(3):411-418. PubMed ID: 29903509
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
10. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
11. Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy.
Ha H; Nam AR; Bang JH; Park JE; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ; Oh DY
Oncotarget; 2016 Nov; 7(47):76604-76612. PubMed ID: 27780932
[TBL] [Abstract][Full Text] [Related]
12. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
[TBL] [Abstract][Full Text] [Related]
13. The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.
Sellers CM; Uhlig J; Ludwig JM; Pollak JS; Taddei TH; Stein SM; Lim JK; Kim HS
Cancer Med; 2021 Aug; 10(16):5395-5404. PubMed ID: 34318618
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of preoperative peripheral blood neutrophil-to-lymphocyte ratio and γ-glutamyl transpeptidase-to-platelet ratio index in patients with hepatitis B virus related intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Yi Xue Za Zhi; 2021 Oct; 101(38):3134-3140. PubMed ID: 34674423
[No Abstract] [Full Text] [Related]
15. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
Chiu TJ; Chen YJ; Kuo FY; Chen YY
PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
[TBL] [Abstract][Full Text] [Related]
16. Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma.
Lin G; Liu Y; Li S; Mao Y; Wang J; Shuang Z; Chen J; Li S
Oncotarget; 2016 Aug; 7(32):50963-50971. PubMed ID: 26918355
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.
Tan DW; Fu Y; Su Q; Guan MJ; Kong P; Wang SQ; Wang HL
Sci Rep; 2016 Oct; 6():33789. PubMed ID: 27694951
[TBL] [Abstract][Full Text] [Related]
18. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma.
Chen Q; Dai Z; Yin D; Yang LX; Wang Z; Xiao YS; Fan J; Zhou J
Medicine (Baltimore); 2015 Apr; 94(13):e574. PubMed ID: 25837750
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in advanced hepatocellular carcinoma patients treated with anti-PD-1 therapy.
Dharmapuri S; Özbek U; Lin JY; Sung M; Schwartz M; Branch AD; Ang C
Cancer Med; 2020 Jul; 9(14):4962-4970. PubMed ID: 32419290
[TBL] [Abstract][Full Text] [Related]
20. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]